Autoimmunity Following COVID-19 Infection
Dr. Akhil Sood discusses abstract 0795 at ACR22 Convergence.
Abstract 0795: Post-Acute COVID-19 Sequalae (PACS) with New-onset Rheumatological Complications
Best of ACR22 in PsA: Day Three
Dr. Rachel Tate discusses the best PsA content presented on day three (Monday) at ACR22 Convergence in Philadelphia, PA.
Medication Adherence intervention in SLE
Dr. Bella Mehta speaks with Dr. Kai Sun abstract 0063 at ACR22 Convergence in Philadelphia, PA.
Abstract 0063: Implementability of a SLE Medication Adherence Intervention
Peresolimab for RA: Phase 2a Results
Dr. Jonathan Kay abstract L03 at ACR22 Convergence in Philadelphia.
L03: A Phase 2 Trial of Peresolimab for Adults with Rheumatoid Arthritis
We've Got to Talk about CAR T cells
EULAR 2024 Daily Podcasts Day1&2
Predicting Palindromic Prognosis
A Step Closer to Identifying Phenotypes of RA ILD
Top 3 Messages About JAK Inhibitor Safety
Pain in RA: Different Drugs for Different Mechanisms
Giant Cell Arteritis and Polymyalgia Rheumatica Update
JAK Inhibitors for New Indications
Top 3 Messages About JAK Inhibitor Safety
Pain in RA: Different Drugs for Different Mechanisms
JAK Inhibitors for New Indications
Potential of Radiomics to Predict TNF Therapy Outcomes in axSpA
Treat to Target Outcomes in Early AxSpA
Does Telemonitoring in SpA Work?
PsA Treatment: is Earlier Better?
JAK Inhibitors for New Indications
Transition from Psoriasis to PsA: Can we Prevent It?
EULAR 2024 Daily Recap - Days 1 & 2
Mechanistic Promise in RA Doesn’t Always Mean Actual Gain
The Role of Psychosocial Determinants in the Management of Rheumatoid Arthritis
Create your
podcast in
minutes
It is Free
Good Mood Revolution
Good Nurse Bad Nurse
The Relaxback UK Show
On Call With Dr. Anselm Anyoha
The Doctor’s Farmacy with Mark Hyman, M.D.
The Peter Attia Drive